Scottish Health Innovations Ltd
SUBMIT AN IDEA
Do you have an idea that may improve patient care? You can submit your idea on-line. Click here to find out more.
Scottish Innovators honoured at Life Sciences Awards Dinner |
|
Some of Scotland's most groundbreaking scientists have been shortlisted for a prestigious award at the 2009 Scottish Enterprise Life Sciences Annual Awards. The three groups of nominees represent cutting edge research by medical professionals throughout Scotland. The winners of the 2009 Scottish Health Innovations Ltd (SHIL) Award for Best Innovation Originating from NHS Scotland will be announced at the Scottish Enterprise Life Sciences Annual Dinner at the Edinburgh International Conference Centre on 5th February. The nominees for this year's SHIL Award are:- Dr Celestine Santosh and Dr David Brennan from NHS Greater Glasgow and Clyde are working with a team in collaboration with the University of Glasgow to create a product that allows an existing pharmaceutical compound to be used in conjunction with magnetic resonance imaging scanners to aid in the diagnosis and treatment in a number of illnesses. This product would significantly advance patient care in a number of major clinical conditions including stroke, heart attack, cancer, epilepsy, and neurodegenerative diseases. Dr Alastair Cozens from NHS Grampian has been shortlisted for his part in developing the iPAM-Intelligent, a pneumatically assisted movement therapy which helps patients affected by stroke to exercise their upper limbs. The robotic system assists patients with exercises, in addition to conventional therapy with a physiotherapist or occupational therapist. iPAM has been developed by a clinically-led team comprising doctors, physiotherapists and engineers, collaborating closely with a user group of stroke patients and their carers. Professor Sandra MacRury from NHS Highland and Professor Ian Megson from UHI Millennium Institute have been shortlisted for their use of N-acetylcysteine and aspirin in the treatment of thrombosis in diabetic patients. Strokes and heart attacks account for up to 80% of deaths in patients with diabetes, whilst blocked blood vessels are often responsible for the very high incidence of foot and leg amputations in diabetic patients. Diabetic patients are often unresponsive to aspirin, however, the team is researching a combined pill - of N-acetylcysteine and aspirin - which has proven to be a more effective treatment. CEO of SHIL, Dr. Sandy Allan, said: "The calibre of nominees for this year's award exemplifies the high standard of ground breaking work being carried out within hospitals and laboratories throughout Scotland. "The Scottish Enterprise Life Sciences Awards recognise leaders in this field and help to reinforce Scotland's reputation as a world leader in the discovery, creation and manufacture of healthcare products." SHIL works in partnership with NHS Scotland to protect and develop new innovations created by health care professionals. |
Featured Product
Multifocal Imager 3GEN
 |
 |
 |
 |
 |
 |
